TrialPhysiological reports2024

Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib-induced diarrhea in HER2-positive breast cancer-A pilot study.

Joanne Bowen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.